Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,399.00
-50.00 (-3.45%)
At close: Oct 2, 2025
-3.45%
Market Cap12.98B
Revenue (ttm)1.00B
Net Income (ttm)-13.37B
Shares Out9.28M
EPS (ttm)-1,637.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,489
Average Volume4,163
Open1,300.00
Previous Close1,449.00
Day's Range1,250.00 - 1,500.00
52-Week Range680.00 - 2,800.00
Beta-0.05
RSI40.81
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.